Final Results from an International, Multi-Center, Single-Arm Study Evaluating the Safety and Efficacy of Romiplostim in Adults with Primary Immune Thrombocytopenia (ITP),Ann Janssens, Richard Lizambri, Peter A.W. te Boekhorst et al.|Blood|2011Cited by 12
Home Administration of Romiplostim by Patients with Chronic Immune Thrombocytopenia (ITP).Roger M. Lyons, Dietmar Berger, Ralph V. Boccia et al.|Blood|2009Cited by 3
The Effects of Romiplostim or Standard of Care (SOC) on Splenectomy and Treatment Failure of Patients Who Had Immune Thrombocytopenia (ITP) for Less Than or Equal to One Year.Ralph V. Boccia, Richard Lizambri, David J. Kuter et al.|Blood|2010Cited by 2
Use of Rituximab in a Study Comparing the Thrombopoietin Mimetic Romiplostim with Standard of Care (SOC) in Patients with Immune Thrombocytopenia (ITP),Jeffrey S. Wasser, Richard Lizambri, Jean‐François Viallard et al.|Blood|2011Cited by 1